Cumberland Pharmaceuticals Inc. (CPIX)

Market Cap	86.00M +15.9%
Revenue (ttm)	41.94M +2.1%
Net Income	-7.38M
EPS	-0.50
Shares Out	14.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,743
Open	6.10
Previous Close	6.15
Day's Range	5.48 - 6.12
52-Week Range	1.85 - 6.61
Beta	-0.06
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 11, 2009
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: CPIX
• Website: https://www.cumberlandpharma.com

Financial Performance

In 2025, CPIX's revenue was $44.52 million, an increase of 17.57% compared to the previous year's $37.87 million. Losses were -$2.84 million, -56.23% less than in 2024.